Publications Archive for 2003


Novel “anti-reverse” cap analogs with superior translational properties

By Jemielity J, Fowler T., Zuberek J., Stepinski J., Lewdorowicz M., Niedzwiecka A., Stolarski R., Darzynkiewicz E., Rhoads R.E.,

Published in RNA 9 (2003) 1108 - 1122

Synthesis of novel mRNA 5 ‘ cap-analogues: Dinucleoside P-1, P-3-tri-, P-1, P-4-tetra-, and P-1, P-5-pentaphosphates

By Jemielity J., Stepinski J., Jaremko M., Haber D., Stolarski R., Rhoads R.E., Darzynkiewicz E.,

Published in Nucleosides Nucleotides & Nucleic Acids 22 (2003) 691 - 694

Binding studies of eukaryotic initiation factor eIF4E with novel mRNA dinucleotide cap analogues

By Zuberek J., Jemielity J., Stepinski J., Lewdorowicz M., Niedzwiecka A., Haber D., Stolarski R., Rhoads R.E., Darzynkiewicz E.,

Published in Nucleosides Nucleotides & Nucleic Acids 22 (2003) 1703 - 1706

Influence of the length of the phosphate chain in mRNA 5 ‘ cap analogues on their interaction with eukaryotic initiation factor 4E

By Zuberek J., Jemielity J., Niedzwiecka A., Stepinski J., Wyslouch-Cieszynska A., Stolarski R., Darzynkiewicz E.,

Published in Nucleosides Nucleotides & Nucleic Acids 22 (2003) 1707 - 1710

Interaction between yeast eukaryotic initiation factor eIF4E and mRNA 5 ‘ cap analogues differs from that for murine eIF4E

By Kiraga-Motoszko K., Stepinski J., Niedzwiecka A., Jemielity J., Wszelaka-Rylik M., Stolarski R., Zielenkiewicz W., Darzynkiewicz E.,

Published in Nucleosides Nucleotides & Nucleic Acids 22 (2003) 1711 - 1714